- Home
- MATV vs PTCT Comparison
MATV vs PTCT Comparison
Compare MATV & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MATV | PTCT |
|---|---|---|
| Founded | 1995 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Paper | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 644.7M | 5.3B |
| IPO Year | 1995 | 2013 |
Fundamental Metrics
Financial Performance| Metric | MATV | PTCT |
|---|---|---|
| Price | $12.67 | $75.56 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 17 |
| Target Price | $10.00 | ★ $73.76 |
| AVG Volume (30 Days) | 288.6K | ★ 2.2M |
| Earning Date | 11-05-2025 | 11-04-2025 |
| Dividend Yield | ★ 3.17% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 8.94 |
| Revenue | ★ $1,982,500,000.00 | $1,779,150,000.00 |
| Revenue This Year | $2.62 | $128.32 |
| Revenue Next Year | $2.26 | N/A |
| P/E Ratio | ★ N/A | $8.46 |
| Revenue Growth | 0.39 | ★ 97.54 |
| 52 Week Low | $4.34 | $35.95 |
| 52 Week High | $13.57 | $87.50 |
Technical Indicators
Market Signals| Indicator | MATV | PTCT |
|---|---|---|
| Relative Strength Index (RSI) | 57.35 | 50.79 |
| Support Level | $11.78 | $73.09 |
| Resistance Level | $12.26 | $78.77 |
| Average True Range (ATR) | 0.42 | 3.15 |
| MACD | 0.01 | -1.02 |
| Stochastic Oscillator | 65.25 | 18.45 |
Price Performance
Historical ComparisonAbout MATV Mativ Holdings Inc.
Mativ Holdings Inc is a leader in specialty materials, solving its customers' complex challenges by engineering bold, inventive solutions that connect, protect, and purify the world. The company operates in two segments namely Filtration & advanced Materials focused on filtration media and components, developed films, coating and converting solutions, and extruded mesh products, and (2) Sustainable & Adhesive Solutions (SAS), focused on tapes, labels, liners, specialty paper, packaging and healthcare solutions.
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.